Artesunate 13CD4

Artesunate 13CD4 is a synthetic derivative of artemisinin, a compound extracted from the plant Artemisia annua. It is used as an antimalarial drug, specifically in the treatment of severe malaria. Artesunate 13CD4 is a water-soluble, white to off-white, crystalline powder that is stable under normal conditions. It is available in various forms such as tablets, capsules, and injectables. The mechanism of action of Artesunate 13CD4 involves the generation of reactive oxygen species that damage the membranes of the malaria parasite, leading to its death. It is effective against both Plasmodium falciparum and Plasmodium vivax, the two most common species of malaria-causing parasites. Artesunate 13CD4 has been found to be safe and effective in treating severe malaria in both adults and children. It is usually administered intravenously for the first 24 hours, followed by oral medication. The dosage and duration of treatment depend on the severity of the infection, the age and weight of the patient, and other factors that are assessed by a healthcare professional. The chemical formula of Artesunate 13CD4 is C19H28O8, and its molecular weight is 384.43 g/mol. The compound is labeled with 13C isotope, which is a stable, non-radioactive form of carbon. This labeling allows for the tracking of the drug in biological samples using mass spectrometry. Artesunate 13CD4 is a highly purified compound that meets the standards of Good Manufacturing Practices (GMP) and is approved by regulatory authorities for use in the treatment of malaria.